1 – 10 of 23
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Amyloid-PET and 18F-FDG-PET in the diagnostic investigation of Alzheimer's disease and other dementias
(
- Contribution to journal › Scientific review
- 2018
-
Mark
In vivo quantification of glial activation in minipigs overexpressing human α-synuclein
(
- Contribution to journal › Article
-
Mark
Association of cerebral amyloid-β Aggregation with cognitive functioning in persons without dementia
(
- Contribution to journal › Article
-
Mark
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
(
- Contribution to journal › Article
- 2016
-
Mark
Gray and white matter imaging : A biomarker for cognitive impairment in early Parkinson's disease?
(
- Contribution to journal › Article
-
Mark
Hypothalamic volume loss is associated with reduced melatonin output in Parkinson's disease
(
- Contribution to journal › Article
- 2015
-
Mark
The role of pallidal serotonergic function in Parkinson's disease dyskinesias: a positron emission tomography study.
(
- Contribution to journal › Article
-
Mark
Baseline and longitudinal grey matter changes in newly diagnosed Parkinson's disease : ICICLE-PD study
(
- Contribution to journal › Article
-
Mark
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
(
- Contribution to journal › Article
- 2014
-
Mark
Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42: A Cross-Validation Study Against Amyloid Positron Emission Tomography.
(
- Contribution to journal › Article